Analysis of Real‐World Data to Investigate the Impact of Race and Ethnicity on Response to Programmed Cell Death‐1 and Programmed Cell Death‐Ligand 1 Inhibitors in Advanced Non‐Small Cell Lung Cancers

BACKGROUND: Racial disparities among clinical trial participants present a challenge to assess whether trial results can be generalized into patients representing diverse races and ethnicities. The objective of this study was to evaluate the impact of race and ethnicity on treatment response in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayers, Kristin L., Mullaney, Tommy, Zhou, Xiang, Liu, Jane J., Lee, Kyeryoung, Ma, Meng, Jones, Scott, Li, Li, Redfern, Arielle, Jappe, Whitney, Liu, Zongzhi, Goldsweig, Howard, Yadav, Kamlesh K., Hahner, Nicholas, Dietz, Matthew, Zimmerman, Michelle, Prentice, Tony, Newman, Scott, Veluswamy, Rajwanth, Wisnivesky, Juan, Hirsch, Fred R., Oh, William K., Li, Shuyu D., Schadt, Eric E., Chen, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Immuno‐Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265370/
https://www.ncbi.nlm.nih.gov/pubmed/33829580
http://dx.doi.org/10.1002/onco.13780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265370/
https://www.ncbi.nlm.nih.gov/pubmed/33829580
http://dx.doi.org/10.1002/onco.13780

Ejemplares similares